Tag: cross-reactivity

Apr 19, 2026

• cross-reactivity
• ADE
• neutralisation
• IgG
• IgA
• IgM
• IgG3
• IgG4
• serotype
• E-protein
• NS1
• EDI-II
• EDIII
• flavivirus
• diagnostics
• vaccine
• longitudinal
• antibody-kinetics
• anti-prM
• prM
• structural-antibody
• anti-endothelial
• anti-platelet
• Vietnam
• infection-order

Apr 19, 2026

• serotype
• DENV-1
• epidemiology
• secondary-infection
• ADE
• Singapore
• Nicaragua
• antibody-kinetics
• anti-prM
• cross-reactivity
• NS1-levels
• viraemia

Apr 19, 2026

• serotype
• DENV-3
• Cuba
• displacement
• epidemic-dynamics
• CNS-invasion
• neuropathogenesis
• Singapore
• Taiwan
• Nicaragua
• anti-platelet
• IgM
• primary-infection
• antibody-kinetics
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity

Apr 18, 2026

• serology
• IgM
• IgG
• ELISA
• diagnostics
• convalescent-phase
• secondary-infection
• Zika
• cross-reactivity
• MAC-ELISA
• anti-dengue-IgG
• anticardiolipin
• anti-prM
• research-ELISA
• India

Apr 18, 2026

• differential-diagnosis
• dengue-mimickers
• clinical-review
• infectious-disease
• rheumatology
• SLE
• autoimmunity
• arboviruses
• chikungunya
• zika
• malaria
• leptospirosis
• neurological
• hematological
• ITP
• Brazil
• arbovirus-coinfection
• cross-reactivity
• acute-abdomen

Apr 17, 2026

• serotype
• DENV-2
• Asian-genotype
• virulence
• ADE
• secondary-infection
• Cuba
• CNS-invasion
• neuropathogenesis
• anti-platelet
• IgM
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity
• NS3
• salivary-gland-replication

Apr 17, 2026

• serotype
• DENV-4
• Cuba
• epidemic
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity